These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33538125)

  • 1. Cancer-associated-platelet-inspired nanomedicines for cancer therapy.
    Geranpayehvaghei M; Dabirmanesh B; Khaledi M; Atabakhshi-Kashi M; Gao C; Taleb M; Zhang Y; Khajeh K; Nie G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1702. PubMed ID: 33538125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired and Biomimetic Nanomedicines.
    Chen Z; Wang Z; Gu Z
    Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation.
    Raghunathan S; Rayes J; Sen Gupta A
    J Thromb Haemost; 2022 Jul; 20(7):1535-1549. PubMed ID: 35435322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy.
    Zhang Y; Liu G; Wei J; Nie G
    Front Med; 2018 Dec; 12(6):667-677. PubMed ID: 29619757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.
    Xu XR; Zhang D; Oswald BE; Carrim N; Wang X; Hou Y; Zhang Q; Lavalle C; McKeown T; Marshall AH; Ni H
    Crit Rev Clin Lab Sci; 2016 Dec; 53(6):409-30. PubMed ID: 27282765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy.
    Yang K; Yang Z; Yu G; Nie Z; Wang R; Chen X
    Adv Mater; 2022 Feb; 34(6):e2107434. PubMed ID: 34693571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents.
    Xu XR; Yousef GM; Ni H
    Blood; 2018 Apr; 131(16):1777-1789. PubMed ID: 29519806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis.
    Shi Q; Ji T; Tang X; Guo W
    Cell Oncol (Dordr); 2023 Jun; 46(3):521-532. PubMed ID: 36652166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the thrombus: Platelet-inspired nanomedicine approaches in inflammation, immune response, and cancer.
    Desai C; Koupenova M; Machlus KR; Sen Gupta A
    J Thromb Haemost; 2022 Jul; 20(7):1523-1534. PubMed ID: 35441793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
    Kwon S; Ko H; You DG; Kataoka K; Park JH
    Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prospects of microphysiological systems in modeling platelet pathophysiology in cancer.
    Ghosh LD; Jain A
    Platelets; 2023 Dec; 34(1):2247489. PubMed ID: 37610007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor vasculature-targeting nanomedicines.
    Zhang Y; He J
    Acta Biomater; 2021 Oct; 134():1-12. PubMed ID: 34271167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Targeted Nanomedicine for Immunotherapy.
    Cabral H; Kinoh H; Kataoka K
    Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
    Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
    Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-promoting drug delivery efficiency for inhibition of tumor growth, metastasis, and recurrence.
    Li X; Hu L; Tan C; Wang X; Ran Q; Chen L; Li Z
    Front Oncol; 2022; 12():983874. PubMed ID: 36276066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of protein corona for nanomedicines.
    Li T; Wang Y; Zhou D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1982. PubMed ID: 39004508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancement of platelet-inspired nanomedicine.
    Wang S; Yuan J; Yang J; Li N; Liu R; Luan J; Ye D
    Platelets; 2018 Nov; 29(7):690-694. PubMed ID: 29883255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses.
    Matus MF; Vilos C; Cisterna BA; Fuentes E; Palomo I
    Vascul Pharmacol; 2018 Feb; 101():1-8. PubMed ID: 29174014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platelet contribution to cancer progression.
    Bambace NM; Holmes CE
    J Thromb Haemost; 2011 Feb; 9(2):237-49. PubMed ID: 21040448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.